DANIEL EGNACHESKI: Open Payments
NPI 1124731005 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,744 in 97 payments from 14 companies in 2025. Trend: 2023 $2,181 · 2024 $1,751 · 2025 $1,744
Food & beverage: $1,633Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $364 |
| ABBVIE INC. | 14 | $243 |
| Lundbeck LLC | 11 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $185 |
| E.R. Squibb & Sons, L.L.C. | 7 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $127 |
| Janssen Pharmaceuticals, Inc | 5 | $109 |
| Alkermes, Inc. | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Neurocrine BioSciences, Inc. | 4 | $62 |
Products named: VRAYLAR, AUSTEDO XR, TRINTELLIX, COBENFY, REXULTI, ABILIFY MAINTENA, CAPLYTA, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
